138 related articles for article (PubMed ID: 1337514)
21. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
[TBL] [Abstract][Full Text] [Related]
22. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH
Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of combinated transcatheter hepatic artery chemoembolization and factors affecting the prognosis in patients with primary hepatic carcinoma].
Li CX; Zhang Y; Gao L
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):942-5. PubMed ID: 17533749
[TBL] [Abstract][Full Text] [Related]
24. Combined transcatheter arterial embolization and expanded liver resection for hepatocellular carcinoma with multiple intrahepatic metastasis.
Tanaka A; Kumada K; Yamaoka Y; Ozawa K
Am J Gastroenterol; 1992 Oct; 87(10):1496-8. PubMed ID: 1329496
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection].
Li JQ; Zhang YQ; Zhang WZ
Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):387-9. PubMed ID: 7895595
[TBL] [Abstract][Full Text] [Related]
26. Preservation of segment 4 inferior by distal middle hepatic vein reconstruction combined with extended right hepatectomy after portal vein embolization in a patient with a huge initially unresectable HCC.
Nakano H; Kikuchi K; Seta S; Katayama M; Yamamura T; Otsubo T
Hepatogastroenterology; 2007; 54(77):1563-6. PubMed ID: 17708300
[TBL] [Abstract][Full Text] [Related]
27. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
28. [A case report: disappearance of cancer cells confirmed by surgical resection after transcatheter hepatic artery embolization (TAE) for ruptured hepatocellular carcinoma].
Wakahara M; Tanaka S; Tanemura H; Ooshita H; Kanno A; Hiraoka T; Suhara T; Nakata T; Yamamoto M; Saitou S
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1903-6. PubMed ID: 10560422
[TBL] [Abstract][Full Text] [Related]
29. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
30. Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization.
Kobayashi A; Takahashi S; Ishii H; Konishi M; Nakagohri T; Gotohda N; Satake M; Furuse J; Kinoshita T
Eur J Surg Oncol; 2007 Oct; 33(8):1019-24. PubMed ID: 17399939
[TBL] [Abstract][Full Text] [Related]
31. [Prevention of postoperative recurrence of hepatocellular carcinoma by adjuvant locoregional chemotherapy].
Izumi R; Shimizu K; Kiriyama M; Ii T; Iwasa K; Iyobe T; Masutani H; Yagi M; Miyazaki I; Matsui O
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1497-500. PubMed ID: 1326916
[TBL] [Abstract][Full Text] [Related]
32. [Cytofluorometric and histopathological studies on non-cancerous liver lesions after lipiodol-transcatheter arterial embolization].
Shimotsuma M; Taniguchi H; Sawai K; Takahashi T; Kagawa K; Kamachi M; Ashihara T; Shimamura Y
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2460-4. PubMed ID: 2843109
[TBL] [Abstract][Full Text] [Related]
33. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
34. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
[TBL] [Abstract][Full Text] [Related]
35. [Chemoembolization therapy with cisplatin.lipiodol (CDDP.lipiodol) in primary liver cancer--with special reference to hepatocellular carcinoma].
Yodono H; Tarusawa K; Kanehira J; Fukuda E; Ikami I; Sakaki T; Kamata K; Sasaki D; Sasaki M
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3476-82. PubMed ID: 3024580
[TBL] [Abstract][Full Text] [Related]
36. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
[TBL] [Abstract][Full Text] [Related]
37. Response to transcatheter oily chemoembolization in hepatocellular carcinoma 3 cm or less: a study in 50 patients who underwent surgery.
Nakamura H; Liu T; Hori S; Mitani H; Murakami T; Kozuka T; Kuroda C; Monden M; Sakurai M; Wakasa K
Hepatogastroenterology; 1993 Feb; 40(1):6-9. PubMed ID: 8385064
[TBL] [Abstract][Full Text] [Related]
38. [Histologic assessment on resected hepatocellular carcinoma specimens with preoperative transcatheter hepatic arterial chemo-embolizations].
Chen H
Zhonghua Wai Ke Za Zhi; 1991 Feb; 29(2):90-2, 141. PubMed ID: 1650685
[TBL] [Abstract][Full Text] [Related]
39. [A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension].
Takeda M; Mizuguchi N; Ohyama Y; Suzuki S; Itoh M; Mukojima T; Kumagai T; Iwasaki H
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1367-70. PubMed ID: 1648891
[TBL] [Abstract][Full Text] [Related]
40. [Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study].
Kawai S; Tani M; Mikuriya S; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Jinno K; Makino M; Oda T
Gan To Kagaku Ryoho; 1990 Feb; 17(2):227-32. PubMed ID: 2154160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
